What's in Laboratorios Leti, S.L.'s pipeline?

Laboratorios Leti, S.L. has 3 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Laboratorios Leti, S.L.'s portfolio?

Top competitors by shared drug class: HAL Allergy, Allergopharma GmbH & Co. KG, Anergis, Beijing Tongren Hospital, Clinique Spécialisée en Allergies de la Capitale.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/laboratorios-leti-s-l.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Laboratorios Leti, S.L. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laboratorios Leti, S.L. pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Cupressus arizonica	Cupressus arizonica	marketed	Allergen immunotherapy	Allergy/Immunology
Artemisia vulgaris	Artemisia vulgaris	marketed		Immunology
Depigoid Parietaria judaica 1000DPP/ml	Depigoid Parietaria judaica 1000DPP/ml	phase 3	Allergen immunotherapy extract	Immunology / Allergy

Therapeutic area mix

Allergy/Immunology · 1
Immunology · 1
Immunology / Allergy · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

HAL Allergy · 2 shared drug classes
Allergopharma GmbH & Co. KG · 1 shared drug class
Anergis · 1 shared drug class
Beijing Tongren Hospital · 1 shared drug class
Clinique Spécialisée en Allergies de la Capitale · 1 shared drug class
Johns Hopkins University · 1 shared drug class
Medical University of Silesia · 1 shared drug class
National Taiwan University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Laboratorios Leti, S.L.:

Cite this brief

Drug Landscape (2026). Laboratorios Leti, S.L. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/laboratorios-leti-s-l. Accessed 2026-05-16.